Brief: Idera Pharmaceuticals Acquires Aceragen
29/09/2022 10:35
Sept 29 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS ACQUIRES ACERAGEN
* IDERA PHARMACEUTICALS INC - ACQUISITION OF ACERAGEN WAS
STRUCTURED AS A STOCK-FOR-STOCK TRANSACTION
Source text for Eikon: ID:nGNX3mnDXM
Further company coverage: IDRA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary